adverse events. For monitoring recommendations, critical outcomes were disease-related outcomes, responsiveness/sensitivity to change of the test as a surrogate for disease-related outcomes, and testing-related adverse events. RESULTS/RECOMMENDATIONS Based on 24 PICO questions, the panel developed 15 screening and monitoring recommendations (Tables 2 3 4 5 Screening for SARD-ILD Who should be screened. It was recognized that RA, SSc, IIM, MCTD, and SjD all confer an increased risk of ILD